Keyphrases
Functional Groups
100%
BRAF V600E
100%
Papillary Thyroid Carcinoma
100%
Key Functional Groups
100%
BRAF V600E mutant
44%
Overall Survival
33%
Group 13
11%
Confidence Interval
11%
Hazard Ratio
11%
Genetic Diversity
11%
Primary Tumor
11%
Aggressive Variant
11%
Mortality Hazard
11%
High Mortality
11%
Additional mutations
11%
Highly Aggressive
11%
Distant Metastasis
11%
Increased Mortality
11%
Mutation Sites
11%
BRAF V600E mutation
11%
SWItch/Sucrose Non-fermentable
11%
PI3K-AKT-mTOR Pathway
11%
Metagenomic Next-generation Sequencing (mNGS)
11%
Histone Methyltransferase
11%
Lent
11%
Aggressive Course
11%
Medicine and Dentistry
Functional Groups
100%
Papillary Thyroid Cancer
100%
Overall Survival
30%
Genetic Variability
10%
Hazard Ratio
10%
Primary Tumor
10%
Distant Metastasis
10%
Next Generation Sequencing
10%
PI3K/AKT/mTOR Pathway
10%
Histone Methyltransferase
10%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Genetic Divergence
33%
Next Generation Sequencing
33%
SWI/SNF
33%
Histone Methyltransferase
33%
PI3K/AKT/mTOR Pathway
33%
Pharmacology, Toxicology and Pharmaceutical Science
Functional Groups
100%
Thyroid Papillary Carcinoma
100%
Overall Survival
30%
Primary Tumor
10%
Distant Metastasis
10%
Histone Methyltransferase
10%